Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Amgen Has A Deflated Stock Price After Great Fourth Quarter Results

The last time I analyzed Amgen (NASDAQ:AMGN) on December 26, 2014 I stated, "Having done this analysis, I'm going to hold off on buying the stock until the carnage in the biotech sector has subsided." It has been a while since I've analyzed the stock and right now I believe it is a good time to do so since the company reported earnings last week. Since the article was published the stock has depreciated 5.23% versus the 4.16% loss the S&P 500 (NYSEARCA: SPY) posted. Amgen is a global biotech company (the first of its kind) which discovers, develops, manufactures and delivers human…